Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 11, 2004 - Issue 2
84
Views
196
CrossRef citations to date
0
Altmetric
Research Article

Peroxynitrite and Vascular Endothelial Dysfunction in Diabetes Mellitus

, &
Pages 89-97 | Published online: 13 Jul 2009

REFERENCES

  • Griendling K. K., Fitz Gerald G. A.. 2003. Oxidant stress and cardiovascular injury. Circulation. 108: 1912–1916. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Moncada S., Higgs E. A.. 1993. The L-arginine-nitric oxide pathway. New England Journal of Medicine. 329: 2002–2012. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Cohen R. A.. 1993. Dysfunction of the vascular endothelium in diabetes mellitus, Circulation. V–67–V-76
  • Crow J. P., Beckman J. S.. 1995. Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Advances in Pharmacology. 34: 17–43. [PUBMED], [INFOTRIEVE]
  • Beckman J. S., Koppenol W. H.. 1996. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. American Journal of Physiology. 271: C1424–C1437. [PUBMED], [INFOTRIEVE]
  • Beckman J. S., Chen J. I., Schiropoulos H., Crow J. P.. 1994. Oxidative chemistry of peroxynitrite. Methods in Enzymology. 233: 229–240. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Hui R. E., Padjama S.. 1993. The reaction of NO with superoxide. Free Radical Research Communications. 18: 195–199
  • Zou M. H., Martin C., Ullrich V.. 1997. Tyrosine nitration as the mechanism of inactivation of prostacyclin synthase by peroxynitrite. Biological Chemistry. 378: 707–713. [PUBMED], [INFOTRIEVE]
  • Zou M. H., Jendral M., Ullrich V.. 1999. Peroxynitrite induces prostaglandin endoperoxide dependent–vasospasm in bovine coronary arteries via nitration of prostacyclin synthase. British Journal of Pharmacology. 126: 1283–1292. [PUBMED], [INFOTRIEVE]
  • Zou M. H., Leist M., Ullrich V.. 1999. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. American Journal of Pathology. 154: 1559–1565
  • Mac, Millan-Crow L. A., Crow J. P., Kerby J. D., Beckman J. S., Thompson A.. 1996. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proceedings of the National Academy of Sciences of the United States of America. 93: 11853–11858. [PUBMED], [INFOTRIEVE]
  • Ischiropoulos H., Duran D., Horwitz J.. 1995. Peroxynitrite-mediated inhibition of DOPA synthesis in PC12 cells. Journal of Neurochemistry. 65: 2366–2372. [PUBMED], [INFOTRIEVE]
  • The Diabetic Control and Complications Trial Research Group, 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 329: 977–986
  • UK Prospective Diabetes Study (UKPDS) Group, 1998. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352: 837–853
  • Kannel W. B., Mc, Gee D. L.. 1979. Diabetes and cardiovascular disease: The Framingham Study. Journal of the American Medical Association. 241: 2035–2038. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Keaney J. F., Jr., Larson M. G., Vasan R. S., Wilson P. W., Lipinska I., Corey D., Massaro J. M., Sutherland P., Vita J. A., Benjamin E. J.. the Framingham Study Investigators, 2003. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 434–439. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Ruderman N. B., Haudenschild C.. 1984. Diabetes as an atherogenic factor. Progress in Cardiovascular Diseases. 6: 373–412
  • Nathan D. M., Lachin J., Cleary P., Orchard T., Brillon D. J., Backlund J. Y., et al, Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group, 2003. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. New England Journal of Medicine. 348: 2294–2303. [PUBMED], [INFOTRIEVE]
  • Reaven G. M., Lithell H., Landsberg L.. 1996. Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoafrenal system. New England Journal of Medicine. 334: 374–381. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Kelly D. E., Mokan M., Simoneau J. A., Mandarion L. J.. 1993. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. Journal of Clinical Investigation. 92: 91–98
  • Steinberg H. O., et al, 2000. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes. 49: 1231–1238. [PUBMED], [INFOTRIEVE]
  • Boden G., Lebed B., Schatz M., Homko C., Lemieux S.. 2001. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes. 50: 1612–1617. [PUBMED], [INFOTRIEVE]
  • Rosen P., Nawroth P. P., King G., Moller W., Tritschler H. J., Packer L.. 2001. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes and Metabolism Research Reviews. 17: 189–212
  • Inoguchi T., et al, 2000. High glucose levels and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NADPH oxidase in cultured vascular cells. Diabetes. 49: 1939–1945. [PUBMED], [INFOTRIEVE]
  • Nishikawa T., Edelstein D., Du X. L., Yamagishi S., Matsomura T., Kaneda Y.. 2000. Normalizing mitochondria superoxide production blocks three pathways of hyperglycemic damage. Nature. 404: 787–790. [PUBMED], [INFOTRIEVE]
  • Aldhahi W., Hamdy O.. 2003. Adipokines, inflammation, and the endothelium in diabetes. Current Diabetes Report. 3: 293–298
  • Retnakaran R., Hanley A. J., Raif N., Connelly P. W., Sermer M., Zinman B.. 2003. C-reactive protein and gestational diabetes: The central role of maternal obesity. Journal of Clinical Endocrinology and Metabolism. 88: 3507–3512. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Tannous M., Rabini R. A., Vignini A., Moretti N., Fumelli P., Zielinski B., Mazzanti L., Mutus B.. 1999. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia. 42: 539–544. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Lyall F., Gibson J. L., Greer I. A., Brockman D. E., Eis A. L.W., Myatt L.. 1998. Increased 3-nitrotyrosine in the diabetic placenta: Evidence for oxidative stress. Diabetes Care. 21: 1753–1758. [PUBMED], [INFOTRIEVE]
  • Ceriello A., Quagliaro L., D'Amico M., Di, Filippo C., Marfella R., Nappo F., Berrino L., Rossi F., Giugliano D.. 2002. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 51: 1076–1082. [PUBMED], [INFOTRIEVE]
  • Frustaci A., et al, 2000. Myocardial cell death in human diabetes. Circ. Res.. 87: 1123–1132. [PUBMED], [INFOTRIEVE]
  • Zou M. H., Shi C., Cohen R. A.. 2002. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with TP receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes. 51: 198–203. [PUBMED], [INFOTRIEVE]
  • Zou M. H., Yesilkaya A., Ullrich V.. 1999. Peroxynitrite inactivates prostacyclin synthase by heme-thiolate-catalyzed tyrosine nitration. Drug Metabolism Reviews. 31: 343–349. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Zou M. H., Daiber A., Peterson J. A., Shoun H., Ullrich V.. 2000. Rapid reactions of heme-thiolate proteins with peroxynitrite as a basis for the inhibition of prostacyclin synthase nitration. Archives in Biochemistry and Biophysics. 376: 149–155
  • Daiber A., Zou M. H., Bachschmid M., Ullrich V.. 1999. The reaction of ebselen with peroxynitrite: In vitro and in vivo. Biochemical Pharmacology. 59: 153–160
  • Schmidt P., Youhnovski N., Daiber A., Balan A., Arsic M., Bachschmid M., Przybylski M., Ullrich V.. 2003. Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. Journal of Biological Chemistry. 278(15)12813–12819. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Zou M. H., Bachschmid M.. 1999. Hypoxia-reoxygenation causes coronary vasospasm via tyrosine nitration of prostacyclin synthase. Journal of Experimental Medicine. 190: 135–139. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Hink U., Oelze M., Kolb P., Bachschmid M., Zou M. H., Daiber A., Mollnau H., August M., Baldus S., Tsilimingas N., Walter U., Ullrich V., Munzel T.. 2003. Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance. Journal of the American College of Cardiology. 42: 1826–1834. [PUBMED], [INFOTRIEVE]
  • Bachschmid M., Thurau S., Zou M. H., Ullrich V.. 2003. Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation. FASEB Journal. 17: 914–916. [PUBMED], [INFOTRIEVE]
  • Zou M. H., Klein T., Pasquet J. P., Ullrich V.. 1998. Interleukin-1β decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite. Biochemical Journal. 336: 507–512. [PUBMED], [INFOTRIEVE]
  • Harrison H. E., Reece A. H., Johnson M.. 1978. Decreased vascular prostacyclin in experimental diabetes. Life Sciences. 23: 351–356. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Dollery C. T., Friedman L. A., Hensby C. N., Kohner E., Lewis P. J., Porta M., Webster J.. 1979. Circulating prostacyclin may be reduced in diabetes. Lancet. ii: 1365
  • Johnson M., Harrison H. E., Raftery A. T., Elder J. B.. 1979. Vascular prostacyclin may be reduced in diabetes in man. Lancet, i. 325–326
  • Silberbauer K., Schernthaner, Sinzinger H.. 1979. Decreased vascular prostacyclin in juvenile-onset diabetes. New England Journal of Medicine. 300: 366–367. [PUBMED], [INFOTRIEVE]
  • Davis T. M.E., Brown E., Finch D. R., Mitchell M. D., Turner R. C.. 1981. In vitro venous prostacyclin production, plasma 6-keto-PGF1α concentrations, and diabetic retinopathy. British Journal of Medicine. 282: 1259–1262
  • Karpen C. W., Pritchard K. A., Jr., Merola A. J., Panganamala R. V.. 1982. Alterations of the prostacyclin-thromboxane ratio in streptozotocin induced diabetic rats. Prostaglandins and Leukocyte Medicine. 8: 93–103
  • Naveh-Floman N., Moisseiev J.. 1982. Prostanoids and thromboxane A2 involvement in diabetic retinopathy. Metabolic, Pediatric, and Systemic Ophthalmology. 6: 321–325. [PUBMED], [INFOTRIEVE]
  • Stuart M. J., Sunderji S. G., Allen J. B.. 1981. Decreased prostacyclin production in the infant of the diabetic mother. Journal of Laboratory and Clinical Medicine. 98: 412–416. [PUBMED], [INFOTRIEVE]
  • Jawerbaum A., Franchi A. M., Gonzalez E. T., Novaro V., de, Gimeno M. A.. 1995. Hyperglycemia promotes elevated generation of TXA2 in isolated rat uteri. Prostaglandins. 50: 47–56. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Hodgson W. C., King R. G., Boura A. L.. 1990. Augmented potentiation of renal vasoconstrictor responses by thromboxane A2 receptor stimulation in the alloxan-diabetic rat. Journal of Pharmacy and Pharmacology. 42: 423–427. [PUBMED], [INFOTRIEVE]
  • Tesfamarian B., Jakubowski J. A., Cohen R. A.. 1989. Contraction of diabetic rabbits aorta due to endothelium-derived PGH2/TxA2. American Journal of Physiology. 257: H13272–H13277
  • Shimizu K., Muramatsu M., Kakegawa Y., Asano H., Toki Y., Miyazaki Y., Okumura K., Hashimoto H., Ito T.. 1993. Role of prostaglandin H2 as an endothelium-derived contracting factor in diabetic state. Diabetes. 42: 1246–1252. [PUBMED], [INFOTRIEVE]
  • Dai F X., Diederich A., Skopec J., Diederich D.. 1993. Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: Role of prostaglandin endoperoxides and free radicals. Journal of the American Society of Nephrology. 4: 1327–1336. [PUBMED], [INFOTRIEVE]
  • Zou M. H., Shi S., Cohen R. A.. 2002. Oxidation by peroxynitrite of zinc-thiolate cluster of eNOS uncouples the enzyme in diabetes. Journal of Clinical Investigation. 109: 817–826. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Kuzkaya N., Weissmann N., Harrison D. G., Dikalov S.. 2003. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: Implications for uncoupling endothelial nitric-oxide synthase. Journal of Biological Chemistry. 278: 22546–22554. [CROSSREF], [PUBMED], [INFOTRIEVE]
  • Landmesser U., Dikalov S., Price S. R., Mc, Cann L., Fukai T., Holland S. M., Mitch W. E., Harrison D. G.. 2003. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. Journal of Clinical Investigation. 111: 1201–1209. [CROSSREF], [PUBMED], [INFOTRIEVE]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.